Improvement of Technique for Pancreatic Islet Cell Isolation and Insulin Producing Cells, and Storage for Transplantation
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Methods".
Deadline for manuscript submissions: closed (28 February 2022) | Viewed by 2725
Special Issue Editor
2. Asan Medical Institute of Convergence Science and Technology (AMIST), Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea
Interests: pancreatic disease; biliary disease; cell therapy
Special Issue Information
Dear Colleagues,
Islet cells in the pancreas are endocrine organs that secrete insulin, which is important for blood sugar control. When islet cells are destroyed by viruses, immune disease or surgery, they cannot produce insulin, leading to severe insulin-dependent diabetes. Metabolic disorders can cause type 2 diabetes due to the loss of balance between diet and exercise. If type 2 diabetes leads to a chronic disability, patients will eventually need treatment with insulin injections outside the body, such as treatment for type 1 or other type of insulin dependent diabetes. Islet transplantation is the most fundamental clinical treatment for diabetes. However, the quality of islet cells required for transplantation is always an important issue. In order to solve this problem, in-depth research is needed on the method to isolate islet cells in good condition, with high yield from the whole pancreas of a cadaver or partial pancreas of pancreatic surgery patients. In addition, the method of freezing and storage of isolated islet cells and thawing them without functional damage after long-term storage will have high value for clinical application. In addition, research on stem cell-based therapy using autologous-induced pluripotent stem cells-derived insulin-producing cells to treat diabetes is being actively conducted by many researchers. This range of studies are of great help in islet cell-based diabetes treatment research and clinical development, so continuous and active research should be conducted.
Dr. Song Cheol Kim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreas islet
- diabetes
- cell transplantation
- insulin producing cells
